Comparison
Why is Zylox-Tonbridge Medical Technology Co., Ltd. ?
- Poor long term growth as Operating profit has grown by an annual rate 29.14% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -160.57
- Over the past year, while the stock has generated a return of -10.35%, its profits have risen by 79.6% ; the PEG ratio of the company is 0.3
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zylox-Tonbridge Medical Technology Co., Ltd. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 9.92%
Highest at HKD 720.51 MM
Fallen by -3.39% (YoY
Highest at HKD 227.99 MM
Highest at 31.64 %
Highest at HKD 229.42 MM
Highest at HKD 204.36 MM
Highest at HKD 0.65
Lowest at 19.69 times
Highest at HKD 3.31 MM
Here's what is working for Zylox-Tonbridge Medical Technology Co., Ltd.
Net Sales (HKD MM)
Net Sales (HKD MM)
Operating Profit (HKD MM)
Operating Profit to Sales
Pre-Tax Profit (HKD MM)
Pre-Tax Profit (HKD MM)
Net Profit (HKD MM)
Net Profit (HKD MM)
EPS (HKD)
Raw Material Cost as a percentage of Sales
Depreciation (HKD MM)
Depreciation (HKD MM)
Here's what is not working for Zylox-Tonbridge Medical Technology Co., Ltd.
Interest Paid (HKD MM)
Debtors Turnover Ratio






